Mortality due to non‑AIDS‑defining cancers among people living with HIV in Spain over 18 years of follow‑up

dc.contributor.authorSuárez-García, Inés
dc.contributor.authorGutiérrez, Félix
dc.contributor.authorPérez Molina, José A.
dc.contributor.authorMoreno, Santiago
dc.contributor.authorAldamiz Echevarría, Teresa
dc.contributor.authorValencia Ortega, Eulalia
dc.contributor.authorCurrán, Adrián
dc.contributor.authorGutiérrez González, Sara
dc.contributor.authorRava, Marta
dc.contributor.authorCoRIS
dc.contributor.authorEt al.
dc.date.accessioned2024-01-14T13:02:14Z
dc.date.available2024-01-14T13:02:14Z
dc.date.issued2023
dc.description.abstractPurpose Our aim was to describe non-AIDS-defining cancer (NADC) mortality among people living with HIV (PLWH), to compare it with that of the general population, and to assess potential risk factors. Methods We included antiretroviral-naive PLWH from the multicentre CoRIS cohort (2004–2021). We estimated mortality rates and standardised mortality ratios (SMRs). We used cause-specific Cox models to identify risk factors. Results Among 17,978 PLWH, NADC caused 21% of all deaths observed during the follow-up. Mortality rate due to NADC was 1.58 (95%CI 1.36, 1.83) × 1000 person-years and lung and liver were the most frequent cancer-related causes of death. PLWH had 79% excess NADC mortality risk compared to the general population with the highest SMR found for Hodgkin lymphoma, anal and liver cancers. The SMRs decreased with age and were the highest in age groups under 50 years. The most important prognostic factor was low CD4 count, followed by smoking, viral hepatitis and HIV transmission through heterosexual contact or injection drug use. Conclusion Non-AIDS cancers are an important cause of death among PLWH. The excess mortality related to certain malignancies and the association with immunodeficiency, smoking, and coinfections highlights the need for early detection and treatment of cancer in this population.spa
dc.description.filiationUEMspa
dc.description.impact2.7 Q3 JCR 2023spa
dc.description.impact1.023 Q1 SJR 2023spa
dc.description.impactNo data IDR 2023spa
dc.description.sponsorshipCIBER -Consorcio Centro de Investigación Biomédica en Red- (CB21/13/00091), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU, the Gilead Scholarship Program for Biomedical Research (GLD19_00106) and the ISCIII- Miguel Servet CP19CIII—00002 contract.spa
dc.identifier.citationSuárez-García, I., Gutierrez, F., Pérez-Molina, J. A., Moreno, S., Aldamiz, T., Valencia Ortega, E., Curran, A., Gutiérrez González, S., Asensi, V., Amador Prous, C., Jarrin, I., Rava, M., & CoRIS. (2023). Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up. Journal of Cancer Research and Clinical Oncology, 149(20), 18161-18171. https://doi.org/10.1007/s00432-023-05500-9spa
dc.identifier.doi10.1007/s00432-023-05500-9
dc.identifier.issn0171-5216
dc.identifier.issn1432-1335
dc.identifier.urihttp://hdl.handle.net/11268/12565
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1007/s00432-023-05500-9spa
dc.rights.accessRightsopen accessspa
dc.subject.unescoCáncerspa
dc.subject.unescoMortalidadspa
dc.subject.unescoSidaspa
dc.titleMortality due to non‑AIDS‑defining cancers among people living with HIV in Spain over 18 years of follow‑upspa
dc.typejournal articlespa
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023 cancer mortality.pdf
Size:
699.41 KB
Format:
Adobe Portable Document Format
Description:
Artículo principal